Day One Biopharmaceuticals Inc

NASDAQ:DAWN  
23.66
+0.38 (+1.63%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Day One Biopharmaceuticals Inc Stock, NASDAQ:DAWN

395 Oyster Point Boulevard, Suite 217, South San Francisco, California 94080
United States of America
Phone: +1.650.484.0899
Number of Employees: 20

Description

Day One Biopharmaceuticals, Inc. operates as a holding company. The firm through its subsidiary develops and commercializes targeted therapies for patients of all ages with genetically defined cancers. Its products include DAY101 and pimsertib. The company was founded by Julie Grant and Samuel Blackman in November 2018 and is headquartered in South San Francisco, CA.